# Thymoorgan Pharmazie Gmbh, Goslar, Germany – FDA Inspections

Source: https://www.keypedia.com/companies/thymoorgan-pharmazie-gmbh/b58b84eb-57d4-4730-8fbb-58632f71023d

> Inspection records and compliance data for Thymoorgan Pharmazie Gmbh in Goslar. 8 FDA inspections on record, 1 Form 483, last inspected April 25, 2023.

---

## Details

- Name: Thymoorgan Pharmazie Gmbh
- FEI Number: 3002320821
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: Schiffgraben 23
- City: Goslar
- Country Name: Germany
- Address: Schiffgraben 23, Goslar, Germany
- Country: Germany

## Related Documents

- [483 - Thymoorgan Pharmazie Gmbh - 2023-04-25](https://www.keypedia.com/records/483/thymoorgan-pharmazie-gmbh/91dc3480-59c7-4907-a84a-4c3bfc75a1ae) — source: FDA, date: April 25, 2023
- [FDA Inspection 1203954 - Thymoorgan Pharmazie Gmbh - 2023-04-25](https://www.keypedia.com/records/fda_inspections/thymoorgan-pharmazie-gmbh/9ff3fdca-2e03-4d87-ab7e-b6d311bbaf32) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 25, 2023
- FDA Inspection 1207607 - Thymoorgan Pharmazie Gmbh - 2022-10-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 6, 2022
- FDA Inspection 1123031 - Thymoorgan Pharmazie Gmbh - 2019-06-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2019
- FDA Inspection 1053793 - Thymoorgan Pharmazie Gmbh - 2018-04-23 — classification: No Action Indicated (NAI), source: FDA, date: April 23, 2018
- FDA Inspection 1003153 - Thymoorgan Pharmazie Gmbh - 2016-12-16 — classification: No Action Indicated (NAI), source: FDA, date: December 16, 2016
- FDA Inspection 943847 - Thymoorgan Pharmazie Gmbh - 2015-09-24 — classification: No Action Indicated (NAI), source: FDA, date: September 24, 2015
- [FDA Inspection 883211 - Thymoorgan Pharmazie Gmbh - 2014-05-22](https://www.keypedia.com/records/fda_inspections/thymoorgan-pharmazie-gmbh/399feebf-70c0-488e-be2c-a34465a28393) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2014
- FDA Inspection 647633 - Thymoorgan Pharmazie Gmbh - 2010-02-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 9, 2010

## Related Companies

- [Takeda GmbH, Plant Oranienburg](https://www.keypedia.com/companies/takeda-gmbh-plant-oranienburg/c72ad117-1d9b-474a-8d1a-c4d0e81e9ba8)
- [Alphapharm Pty, Ltd.](https://www.keypedia.com/companies/alphapharm-pty-ltd/9007b3c5-9b83-4783-b65d-52eb0246708e)
- [Watson Pharma Private Limited](https://www.keypedia.com/companies/watson-pharma-private-limited/846d9c2f-be10-415a-b681-5436e078ebfd)
- [AstraZeneca Nijmegen B.V.](https://www.keypedia.com/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686)
- [Bora Pharmaceuticals Laboratories, Inc](https://www.keypedia.com/companies/bora-pharmaceuticals-laboratories-inc/9bb86ed9-7d7d-4886-a145-b9497462c295)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/80a406f0-7f62-4d81-841e-7f01c9950c06)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/dacc6330-129c-4ce4-8c41-f71525daebe5)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9)
- [Merck Serono S.p.A.](https://www.keypedia.com/companies/merck-serono-spa/052a4b09-0189-4f5c-bdcc-33182a7d3488)
- [IBSA Institut Biochimique SA](https://www.keypedia.com/companies/ibsa-institut-biochimique-sa/b4d0cf36-d7bc-4ea3-851a-9b0efe59255e)

## Related Officers

- [Wayne D. Mcgrath](https://www.keypedia.com/people/wayne-d-mcgrath/42db5ab0-2e0b-4909-951c-e7621cd04f6e)
- [Drug Discovery and Biotech Executive](https://www.keypedia.com/people/lloyd-d-payne/8b98c38a-4fbe-465d-bb0a-689bcc6db702)